CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 96,849	$ 255,303
Restricted cash	135,366	215,325
Accounts receivable, less allowance for doubtful accounts of $4,047 and $3,775 at December 31, 2014 and September 30, 2015, respectively	417,141	353,713
Short-term investments (restricted investments of $132,808 and $260,224 at December 31, 2014 and September 30, 2015, respectively)	361,143	224,361
Deferred income taxes	24,627	27,226
Pharmaceutical inventory	44,652	39,375
Other current assets (restricted deposits of $30,620 and $31,267 at December 31, 2014 and September 30, 2015, respectively)	99,528	52,246
Total Current Assets	1,179,306	1,167,549
Property and equipment, net	177,056	171,916
Restricted long-term investments	9,662	43,293
Other long-term assets	12,729	11,575
Goodwill	623,907	566,106
Other intangible assets, net	141,046	133,718
Total Assets	2,143,706	2,094,157
Current Liabilities:
Accounts payable	100,526	63,929
Accrued liabilities	227,915	154,931
Medical claims payable	263,936	278,482
Other medical liabilities	147,084	72,719
Current maturities of long-term debt and capital lease obligations	16,257	15,779
Total Current Liabilities	755,718	585,840
Long-term debt and capital lease obligations	246,040	255,742
Deferred income taxes	28,548	30,950
Tax contingencies	8,809	12,320
Contingent consideration	1,609	49,839
Deferred credits and other long-term liabilities	19,528	19,951
Total Liabilities	1,060,252	954,642
Redeemable non-controlling interest	$ 8,246	$ 5,957
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2014 and September 30, 2015 - Issued and outstanding-none
Other Stockholders' Equity:
Additional paid-in capital	$ 1,110,523	$ 1,018,266
Retained earnings	1,184,020	1,179,897
Accumulated other comprehensive loss	(114)	(143)
Ordinary common stock in treasury, at cost, 23,150 shares and 25,687 shares at December 31, 2014 and September 30, 2015, respectively	(1,219,734)	(1,064,963)
Total Stockholders' Equity	1,075,208	1,133,558
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity	2,143,706	2,094,157
Ordinary common stock
STOCKHOLDERS' EQUITY
Common stock	$ 513	$ 501
Multi-Vote common stock
STOCKHOLDERS' EQUITY
Common stock